We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealings

11 May 2018 16:10

RNS Number : 8714N
Quixant PLC
11 May 2018
 

Quixant plc

("Quixant" or the "Company")

 

Exercise of Options / Issue of Equity

and Director/PDMR Dealings

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms for gaming and slot machine applications, announces that it has applied to the London Stock Exchange for 313,100 ordinary shares of £0.001 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to exercises of options over Ordinary Shares ("Options") by a Director, certain persons discharging managerial responsibilities ("PDMR's") and other employees of the Company.

 

On 10 May 2018, Cresten Preddy, Finance Director of the Company, exercised Options over 39,000 Ordinary Shares. On Admission Cresten Preddy will hold 79,000 Ordinary Shares, representing approximately 0.12% of the Company's enlarged issued share capital.

 

Furthermore, also on 10 May 2018, the following PDMR's of the Company exercised Options and (in certain cases) subsequently sold Ordinary Shares as follows:

 

PDMR

Role

Options exercised

Ordinary Shares subsequently sold

John Malin

Sales Director, Quixant UK Ltd

15,000

15,000

Stuart Fisher

Finance Director, Quixant UK Ltd

6,150

6,150

Amit Sharma

Vice President Sales & General Manager, Quixant USA Inc

60,000

20,000

Paolo Ruscitti

Manager, Software Engineering, Quixant Italia Srl

20,000

20,000

 

Total Voting Rights

It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 16 May 2018. On Admission the Company's issued share capital will comprise 66,348,082 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 66,348,082 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

Quixant plc

Tel: +44 (0) 1223 892696

Jon Jayal (Chief Executive Officer)

Cresten Preddy (Chief Financial Officer)

 

 

 

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44 (0) 20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (Corporate Broking)

 

 

 

Financial PR:

Tel: +44 (0) 7909 009173

Alma PR

 

John Coles

 

Susie Hudson

 

 

About Quixant

 

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

The information contained in this announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Cresten Preddy - Finance Director

John Malin - Sales Director, Quixant UK Ltd

Stuart Fisher - Finance Director, Quixant UK Ltd

Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

Paolo Ruscitti - Manager, Software Engineering, Quixant Italia Srl

2.

Reason for the notification

a)

Position/status:

See 1 (a) above, all are PDMR's of the Company

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERSWQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Cresten Preddy

- Exercise of options over Ordinary Shares

 

John Malin

- Exercise of options over Ordinary Shares

- Sale of Ordinary Shares

 

Stuart Fisher

- Exercise of options over Ordinary Shares

- Sale of Ordinary Shares

 

Amit Sharma

- Exercise of options over Ordinary Shares

- Sale of Ordinary Shares

 

Paolo Ruscitti

- Exercise of options over Ordinary Shares

- Sale of Ordinary Shares

 

c)

Price(s) and volume(s):

Cresten Preddy

Exercise of Options:

Price(s)

Volume(s)

49 pence

39,000

 

John Malin

Exercise of Options:

Price(s)

Volume(s)

49 pence

15,000

 

Sale of Ordinary Shares:

Price(s)

Volume(s)

430 pence

15,000

 

Stuart Fisher

Exercise of Options:

Price(s)

Volume(s)

158.5 pence

6,150

 

Sale of Ordinary Shares:

Price(s)

Volume(s)

430 pence

6,150

 

Amit Sharma

Exercise of Options:

Price(s)

Volume(s)

49 pence

60,000

 

Sale of Ordinary Shares:

Price(s)

Volume(s)

430 pence

20,000

 

Paolo Ruscitti

Exercise of Options:

Price(s)

Volume(s)

49 pence

20,000

 

Sale of Ordinary Shares:

Price(s)

Volume(s)

430 pence

20,000

 

 

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4 (c) above

e)

Date of the transaction:

10 May 2018

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESFSFIFFASEFI
Date   Source Headline
27th Apr 20234:53 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement and Proposed Name Change
14th Apr 20237:00 amRNSExercise of options
4th Apr 20237:00 amRNSReport and Accounts and Notice of AGM
3rd Apr 20235:52 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of Options
21st Mar 20237:00 amRNSFinal Results
21st Feb 20237:00 amRNSNotice of Results and Investor Presentation
17th Jan 20238:15 amRNSExercise of options
16th Jan 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20238:59 amRNSHolding(s) in Company
3rd Nov 202212:09 pmRNSDirector Shareholding
26th Oct 20228:20 amRNSDirector Shareholding
14th Oct 20227:23 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
13th Sep 20227:00 amRNSAppointment of Non-Executive Directors
6th Sep 20227:00 amRNSInterim Results
1st Sep 20227:00 amRNSMass production order for gaming cabinet solutions
31st Aug 20227:00 amRNSNotice of Results and Presentations
14th Jul 20227:00 amRNSTrading Update and Notice of Results
9th May 20226:04 pmRNSGrant of Options
5th May 202211:55 amRNSResult of AGM
5th May 20227:00 amRNSAGM Statement
11th Apr 202211:37 amRNSReport and Accounts and Notice of AGM
5th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSNotice of Results and Presentations
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update and Notice of Results
29th Oct 20212:28 pmRNSGrant of Options
22nd Sep 20217:00 amRNSInterim Results
15th Sep 20217:00 amRNSInvestor Presentation
5th Aug 202111:16 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSTrading Update and Notice of Results
12th Jul 20213:02 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSAppointment of CFO
1st Jul 20217:00 amRNSDirector Shareholding
6th May 20215:12 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
19th Apr 20216:07 pmRNSHolding(s) in Company
19th Apr 20215:48 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSFinal Results
9th Apr 20214:40 pmRNSRescheduled Investor Presentation
9th Apr 20213:41 pmRNSAnnouncement of Final Results
6th Apr 20217:00 amRNSInvestor Presentation
26th Feb 20217:00 amRNSNotice of Results
12th Feb 20217:00 amRNSAppointment of Joint Broker
27th Jan 20217:00 amRNSTrading Update and Notice of Results
15th Jan 20217:00 amRNSAppointment of New Senior Independent NED
10th Dec 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.